Business Standard

Immune cells associated with protection against Covid-19 identified: Study

The study, published in the journal Science Immunology, assessed T cells from 10 Covid-19 patients under intensive care treatment

vaccine, pharma, coronavirus, medicine, drugs, medical research, covid, lab
Premium

According to the researchers, including those from the University of California in the US, two out of 10 healthy individuals without prior exposure to the virus also harbored SARS-CoV-2-reactive T cells.

Press Trust of India Los Angeles
Patients suffering from severe respiratory symptoms due to the novel coronavirus infection can rapidly generate an immune response in the form of virus-attacking T cells, suggests a new study which may lead to new vaccine development strategies against Covid-19.
The study, published in the journal Science Immunology, assessed T cells from 10 Covid-19 patients under intensive care treatment.
According to the researchers, including those from the University of California in the US, two out of 10 healthy individuals without prior exposure to the virus also harbored SARS-CoV-2-reactive T cells.
Based on this observation, they said these T cells may be cross-reacting to the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in